Z. Goldberg

G. Giaccone, P. Jänne, A. Shaw, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiation-induced effects in unirradiated cells: a review and implications in cancer.

B. Lehnert, Z. Goldberg, 2002, International journal of oncology.

Human In vivo Dose-Response to Controlled, Low-Dose Low Linear Energy Transfer Ionizing Radiation Exposure

David M. Rocke, Christine Hartmann Siantar, Alison Santana, 2006, Clinical Cancer Research.

Clinical implications of radiation-induced genomic instability

Z. Goldberg, 2003, Oncogene.

Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.

C. Paweletz, M. Kris, P. Jänne, 2014, The Lancet. Oncology.

Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.

P. Jänne, K. O'Byrne, T. Mok, 2014, The Lancet. Oncology.

Radiation phantom with humanoid shape and adjustable thickness (RPHAT)

Joerg Lehmann, J. Lehmann, R. Stern, 2004, Physics in medicine and biology.

Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.

J. Crowley, D. Moore, D. Gandara, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dacomitinib (PF-00299804), An Irreversible Pan-Her Tyrosine Kinase Inhibitor (TKI), For First-Line Treatment of EGFR-Mutant or Her2-Mutant or -Amplified Lung Cancers

M. Kris, P. Jänne, S. Ou, 2012 .

Role of a DT-diaphorase mutation in the response of anal canal carcinoma to radiation, 5-fluorouracil, and mitomycin C.

H. Klamut, B. Cummings, W. Chapman, 1998, International journal of radiation oncology, biology, physics.

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.

M. Stockler, L. Seymour, M. Tsao, 2014, The Lancet. Oncology.

Integration of Novel Therapeutics into Combined Modality Therapy of Locally Advanced Non–Small Cell Lung Cancer

D. Gandara, Srinivasan Vijayakumar, P. Gumerlock, 2005, Clinical Cancer Research.

Dosimetry for Quantitative Analysis of the Effects of Low-Dose Ionizing Radiation in Radiation Therapy Patients

David M. Rocke, Joerg Lehmann, David M Rocke, 2006, Radiation research.

Assessing probe-specific dye and slide biases in two-color microarray data

Patrick S. Schnable, Pamela C. Ronald, Geun-Cheol Lee, 2008, BMC Bioinformatics.

Exposure to low dose (1-10 cGy) ionizing radiation: assessment of effects in humans and relevance to cancer

R. Cary, B. Lehnert, R. Stern, 2002 .

A method for detection of differential gene expression in the presence of inter-individual variability in response

David M. Rocke, Zelanna Goldberg, Chad Schweitert, 2005, Bioinform..

Dosimetry for quantitative analysis of low dose ionizing radiation effects on humans in radiation therapy patients

J. Lehmann, R. Stern, T. Daly, 2004 .

Film dosimetry in the peripheral region using multiple sensitometric curves.

J. Lehmann, R. Stern, C. H. Siantar, 2004, Medical Physics (Lancaster).

Multimodality therapy for stage III NSCLC: Controversies, advances, and evolving approaches

D. Gandara, O. Gautschi, R. Calhoun, 2006 .

Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation.

L. Beckett, P. Gumerlock, Yueju Li, 2004, International journal of radiation oncology, biology, physics.

Analysis of treatment for small cell cancer of the bladder and report of three cases.

R. deVere White, L. Ellison, R. Gandour-Edwards, 2004, Urology.

A multicenter, open-label phase Ib/II study to assess the safety and clinical activity of intravenous combretastatin A1 diphosphate (OXi4503) as monotherapy in subjects with primary or secondary hepatic tumor burden.

M. Brown, M. Millward, P. Mainwaring, 2010 .

Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.

J. Purdy, Srinivasan Vijayakumar, R. Stern, 2006, International journal of radiation oncology, biology, physics.

First-Line Dacomitinib (PF-00299804), an Irreversible Pan-Her Tyrosine Kinase Inhibitor, for Patients with EGFR-Mutant Lung Cancers

M. Kris, P. Jänne, S. Ou, 2012 .

An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin.

G. Birrell, Z. Goldberg, J. Evans, 2001, International journal of radiation oncology, biology, physics.

A phase I trial of stereotactic external beam radiation for subfoveal choroidal neovascular membranes in age-related macular degeneration.

A. Barak, J. Handa, L. Morse, 2005, The British journal of radiology.

Abstract CT208: Absolute bioavailability of dacomitinib (PF-00299804): Comparison of oral and intravenous administration in healthy volunteers

R. Labadie, Yali Liang, N. Giri, 2014 .

187TiP Phase II, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumours

A. Jimeno, S. Gettinger, H. Kluger, 2021, Journal of Thoracic Oncology.

A Phase II Study of Paclitaxel, Carboplatin, and Radiation with or without Surgery for Esophageal Cancer

R. Bold, S. Narayan, J. Ryu, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.

C. Paweletz, M. Kris, P. Jänne, 2014, The Lancet. Oncology.

353 Safety and efficacy of tumor infiltrating lymphocytes (TIL, LN-145) in combination with pembrolizumab for advanced, recurrent or metastatic HNSCC

A. Jimeno, M. Haigentz, S. Papa, 2020 .

Molecular Mechanisms of Nonlinearity in Response to Low Dose Ionizing Radiation

David M. Rocke, Z. Goldberg, 2007 .